Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2513 (LINC02513)

Target
LINC02513
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC02513 is a long intergenic non-protein coding RNA gene in humans, annotated as producing non-coding RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes[1][3]. Like other lincRNAs, LINC02513 may play roles in fine-tuning the expression of neighboring genes, chromatin architecture, and transcriptional regulation, but its specific biological function, disease association, and details regarding molecular mechanisms remain largely uncharacterized in the scientific literature[1][3][7]. LINC02513 exemplifies the rapidly expanding class of lincRNAs that are recognized for their regulatory roles in the genome but are not usually considered receptors, enzymes, or conventional therapeutic targets[1][3][7]. Current data do not link LINC02513 to any drug interactions, mechanisms of action, or clinical biomarkers, and there are no known safety/toxicity issues relevant to therapy. The gene's primary relevance is in basic research relating to the non-coding transcriptome.

Other names
long intergenic non-coding RNA 2513
02

Biological functions

Regulation of gene expression (primarily through transcriptional and epigenetic mechanisms)Chromatin remodelingRNA stabilizationPossible enhancer-associated activityOther (these functions are general to lincRNAs and are not yet ascribed specifically to LINC02513 due to limited functional annotation)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2513 (LINC02513).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2513 (LINC02513).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call